EMD-54814

Single-particle
3.7 Å
EMD-54814
3D View Gallery
Deposition: 19/08/2025
Map released: 02/09/2026
Last modified: 02/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-54814

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9sf5 summary report (pdf.gz) Map-9sf5 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

KP.3 SARS-CoV2 with fab JN-1.6 local refinement

EMD-54814

Single-particle
3.7 Å
EMD-54814
3D View Gallery
Deposition: 19/08/2025
Map released: 02/09/2026
Last modified: 02/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: Trimeric complex of JN.1-9 fab with SARS-CoV2 KP.3 Spike glycoprotein subunit.
Fitted models: 9sf5

Deposition Authors: Duyvesteyn HME, Ren J, Stuart DI

Unusual broadly neutralising antibodies elicited by vaccine breakthrough infections by SARS-CoV-2 JN.1
Duyvesteyn HME, Stuart DI, Ren J
To Be Published